相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study
Hiroaki Ikezaki et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
A New Equation Based on the Standard Lipid Panel for Calculating Small Dense Low-Density Lipoprotein-Cholesterol and Its Use as a Risk-Enhancer Test
Maureen Sampson et al.
CLINICAL CHEMISTRY (2021)
Small dense low-density lipoprotein: Analytical review
Christina Kanonidou
CLINICA CHIMICA ACTA (2021)
Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group
Peter W. F. Wilson et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2021)
Methodological issues regarding: A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals
Alan T. Remaley et al.
ATHEROSCLEROSIS (2020)
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
Jan Boren et al.
EUROPEAN HEART JOURNAL (2020)
Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: a prospective, observational cohort study
Jing-Lu Jin et al.
CARDIOVASCULAR DIABETOLOGY (2020)
LDL subclass lipidomics in atherogenic dyslipidemia: effect of statin therapy on bioactive lipids and dense LDL[S]
M. John Chapman et al.
JOURNAL OF LIPID RESEARCH (2020)
Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease
Edward K. Duran et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Small Dense Low-Density Lipoprotein Cholesterol Predicts Atherosclerotic Cardiovascular Disease in the Copenhagen General Population Study
Mie Balling et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Impact of a 2-year trial of nutritional ketosis on indices of cardiovascular disease risk in patients with type 2 diabetes
Shaminie J. Athinarayanan et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Association of small, dense LDL-cholesterol concentration and lipoprotein particle characteristics with coronary heart disease: A systematic review and meta-analysis
Lathan Liou et al.
PLOS ONE (2020)
Apolipoprotein B Particles and Cardiovascular Disease A Narrative Review
Allan D. Sniderman et al.
JAMA CARDIOLOGY (2019)
Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatin
Nuntakorn Thongtang et al.
JOURNAL OF LIPID RESEARCH (2017)
Effects of a very high saturated fat diet on LDL particles in adults with atherogenic dyslipidemia: A randomized controlled trial
Sally Chiu et al.
PLOS ONE (2017)
Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial
Samia Mora et al.
CIRCULATION (2015)
Changes in LDL particle concentrations after treatment with the cholesteryl ester transfer protein inhibitor anacetrapib alone or in combination with atorvastatin
Ronald M. Krauss et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2015)
New Automated Assay of Small Dense Low-Density Lipoprotein Cholesterol Identifies Risk of Coronary Heart Disease The Multi-Ethnic Study of Atherosclerosis
Michael Y. Tsai et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
All Low-Density Lipoprotein Particles Are Not Created Equal
Ronald M. Krauss
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Small Dense Low-Density Lipoprotein-Cholesterol Concentrations Predict Risk for Coronary Heart Disease The Atherosclerosis Risk in Communities ( ARIC) Study
Ron C. Hoogeveen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Comparison of four methods of analysis of lipoprotein particle subfractions for their association with angiographic progression of coronary artery disease
Paul T. Williams et al.
ATHEROSCLEROSIS (2014)
Effects of rosuvastatin versus atorvastatin on small dense low-density lipoprotein: a meta-analysis of randomized trials
Hisato Takagi et al.
HEART AND VESSELS (2014)
Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins
Iris Postmus et al.
NATURE COMMUNICATIONS (2014)
Evaluation of a new homogenous method for detection of small dense LDL cholesterol: Comparison with the LDL cholesterol profile obtained by density gradient ultracentrifugation
John J. Albers et al.
CLINICA CHIMICA ACTA (2011)
Development of a Homogeneous Assay for Measurement of Small Dense LDL Cholesterol
Yasuki Ito et al.
CLINICAL CHEMISTRY (2011)
Susceptibility of LDL and its subfractions to glycation
Handrean Soran et al.
CURRENT OPINION IN LIPIDOLOGY (2011)
Apolipoprotein CIII bound to apoB-containing lipoproteins is associated with small, dense LDL independent of plasma triglyceride levels in healthy men
Min-Jeong Shin et al.
ATHEROSCLEROSIS (2010)
From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus
Kiran Musunuru et al.
NATURE (2010)
Ion Mobility Analysis of Lipoprotein Subfractions Identifies Three Independent Axes of Cardiovascular Risk
Kiran Musunuru et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA)
Samia Mora et al.
ATHEROSCLEROSIS (2007)
Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction?
I Jungner et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the veterans affairs high-density lipoprotein intervention trial
JD Otvos et al.
CIRCULATION (2006)
Phenotypic predictors of response to Simvastatin therapy among African-Americans and Caucasians:: The Cholesterol and Pharmaeogenetics (CAP) Study
JA Simon et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel
PJ Barter et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: Relationship to multiple lipoprotein phenotype
AM Georgieva et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Phenotype-dependent and -independent actions of rosuvastatin on atherogenic lipoprotein subfractions in hyperlipidaemia
MJ Caslake et al.
ATHEROSCLEROSIS (2003)
Metabolic origins and clinical significance of LDL heterogeneity
KK Berneis et al.
JOURNAL OF LIPID RESEARCH (2002)
Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux
M Guerin et al.
ATHEROSCLEROSIS (2002)
分享论文
